Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ACGCGGACTCCCCGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATA| |TTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGG
End
76868620/76641494 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/1550580; hsa-mir-10b/Downstream/3007800;
Upstream sequence
aggtaatacatgcaaaatatataaataaacagaaagagggctggcctacagtaagtgttcaataTTTCTACCTATAGTTTTTATTAGCTATTTTTGTCTA
Downstream sequence
TTCTAGTCCTGGTCATAACGTATGAAAAGATAAAcctggcacaacgcttggtgcaaagatggtgctcagaaaatgttgattgaattaatTTTCTCCTGAG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.